From the survey paper "The future of clinical trials and drug development: 2050":
“Who will run pharma? Google, Amazon, Apple – the big tech companies.”
The opinion was that, try as they might, Blue-chip pharmaceutical companies and mega contract research organization (CRO) conglomerates have already lost the data initiative. It was clear from delegate feedback that we are already seeing technology companies come to the fore as pharma’s trillion dollar spend attracts predators like Google, IBM and Microsoft.
...
The consensus was that, by 2050, if you are working in clinical trials and you are not the janitor, then you are a data scientist, probably working at Google.
This market would resolve as 'yes' if any of the following is true:
these companies have a combined $1 billion dollars or more investments in their own pharma efforts, starting from market opening
these companies have a combined $1 billion or more in pharma acquisitions, starting from market opening
these companies have IP ownership of at least 10 drugs currently in human trials or approved
1,000
3.00
Google released a multimodal medical LLM a few days ago. While this is not focused on pharmaceutical discovery at all, it shows some interest in the sector.
What is this?
What is Manifold?
Are our predictions accurate?
How do I win cash prizes?
and can't be cashed out. to participate and winners can withdraw sweepcash as a cash prize. You can filter for sweepstakes markets on the browse page.1.00Related questions
What is this?
What is Manifold?
Are our predictions accurate?
How do I win cash prizes?
and can't be cashed out. to participate and winners can withdraw sweepcash as a cash prize. You can filter for sweepstakes markets on the browse page.1.00